Sinopharm, a state-run pharmaceutical company in China, has started offering experimental COVID-19 vaccines of late. Lakhs of Chinese students, who will be leaving the country between November 2020 and January 2021, are eligible to be administered with the vaccine.

Wall Street Journal has quoted the company website as saying that 481,613 students have already been given the vaccine. Nearly one lakh students have been inoculated in addition.

So far, students living in Beijing and Wuhan have been given the vaccine.

However, Guardian has reported that a few students from these places have claimed that the vaccination program has been suspended. This has apparently created some confusion. Different media outlets have reported the situation differently. The company website, at the moment, is under maintenance.

Meanwhile, scientist Hilda Bastian has shared a report that says emergency use authorization for Chinese vaccines is coming in November for Indonesia. "Millions of doses will arrive for vaccination of priority workers (medical, military, education, public services)," a report in Maritim says.